Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07021430

Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy

Conditions: Malaria Prevention

Sex: All

Healthy volunteers: Yes

Phase: EARLY_PHASE1

Enrollment: 300

Sponsor: University of North Carolina, Chapel Hill

Location: Bugoye Level III Health Center Kasese Uganda

Summary

The purpose of this study is to demonstrate the feasibility, acceptability, and preliminary effectiveness of a focal mass drug administration program for household members of pregnant women to protect against malaria in pregnancy.

Eligibility Criteria

Inclusion Criteria: * Primary residence (i.e., where a person lives for ≥ 6 months per year) in Kasese District with no plans to change residency in subsequent 6 months * Able and willing to comply with all study procedures and be available for the duration of the study * Able and willing to consent to study procedures as documented on informed consent form. For children (age \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07021430). StuddyBuddy aggregates publicly available trial information.